Biotechnology Company Regains Compliance With The Nasdaq
Scinai Immunotherapeutics Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement.
Disclaimer: The information provided in this article is for informational purposes only and should not be considered as investment advice. Readers are encouraged to perform their own due diligence or consult with a financial advisor before making any investment decisions.
As an investor it's important to stay updated with major ne…